GPT Healthcare's Evaluation Score Adjusted Amidst Market Dynamics and Investor Trends
GPT Healthcare has recently adjusted its evaluation score, reflecting various market dynamics and technical indicators. The company showcases strong management efficiency with a high Return on Capital Employed and a low Debt to EBITDA ratio. However, it has faced challenges, including decreased institutional investor participation and underperformance relative to the BSE 500 index.
GPT Healthcare, a small-cap player in the Hospital & Healthcare Services industry, has recently undergone an adjustment in its evaluation score. This revision reflects a combination of technical indicators and market dynamics that have influenced the stock's standing.The company has demonstrated a high level of management efficiency, evidenced by a robust Return on Capital Employed (ROCE) of 29.06%. Additionally, GPT Healthcare maintains a low Debt to EBITDA ratio of 0.40 times, indicating a strong capacity to service its debt obligations. With a Return on Equity (ROE) of 21.6 and a Price to Book Value ratio of 5.5, the stock presents an attractive valuation profile.
Despite these strengths, the stock has faced challenges, including a decline in institutional investor participation, which has seen a reduction of 0.68% in their stakes over the previous quarter. This trend may reflect broader market sentiments, as GPT Healthcare has underperformed relative to the BSE 500 index, generating negative returns of -14.66% over the past year.
Overall, the adjustment in evaluation for GPT Healthcare highlights the complexities of its current market position and the interplay of various financial metrics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
